Investigating the Effect of Acceptance and Commitment Therapy (ACT) in Peyronie’s Disease

Calculating the Contribution of Flexibility Components in Predicting Sexual Distress and Satisfaction Based on Intimacy and Attachment Orientation in Men with Sexual Dysfunction and Investigating the Efficacy of Acceptance and Commitment Therapy Based on the Most Contributions Components on Sexual Distress and Satisfaction in Men Recovered from Peyronie's Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240705062335N1

Enrollment

Registered

2024-08-12

Start date

2024-09-22

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peyronie. Induration penis plastica

Interventions

Intervention group: considering that the current study is a single case intervention, therefore each subject is considered his own control group. In this study, 3 subjects are subjected to a pre-test

Eligibility

Sex/Gender

Male

Age

25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having at least a diploma Being sexually active Existence of high sexual distress and low sexual satisfaction based on the Multidimensional Sexuality Questionnaire (MSQ)

Exclusion criteria

Exclusion criteria: Absence of one session of treatment sessions Suffering from severe psychological disorders based on the SCL90 questionnaire Suffering from sexual dysfunction based on the BMSFI screening questionnaire and clinical interview History of diabetes, cardiovascular and neurological diseases History of prostate or pelvic surgery Drug and alcohol addiction Taking psychiatric medications

Design outcomes

Primary

Measure	Time frame
The score that a person obtains in the sexual anxiety and sexual depression subscales of the Multidimensional Sexuality Questionnaire. Timepoint: Measuring sexual anxiety and sexual depression before starting the intervention and 7, 14, 21, 28 and 60 days after starting to receive the Acceptance and Commitment Therapy. Method of measurement: Multidimensional Sexuality Questionnaire.;Individual's score in the sexual satisfaction subscale of the Multidimensional Sexuality Questionnaire. Timepoint: Measuring sexual satisfactory before starting the intervention and 7, 14, 21, 28 and 60 days after starting to receive the Acceptance and Commitment Therapy. Method of measurement: Multidimensional Sexuality Questionnaire.	—

Measure

Time frame

The score that a person obtains in the sexual anxiety and sexual depression subscales of the Multidimensional Sexuality Questionnaire. Timepoint: Measuring sexual anxiety and sexual depression before starting the intervention and 7, 14, 21, 28 and 60 days after starting to receive the Acceptance and Commitment Therapy. Method of measurement: Multidimensional Sexuality Questionnaire.;Individual's score in the sexual satisfaction subscale of the Multidimensional Sexuality Questionnaire. Timepoint: Measuring sexual satisfactory before starting the intervention and 7, 14, 21, 28 and 60 days after starting to receive the Acceptance and Commitment Therapy. Method of measurement: Multidimensional Sexuality Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ahmadi

Shahed University

mohammad-ahmadi@shahed.ac.ir+98 87 3523 2064

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026